Condition or disease | Intervention/treatment |
---|---|
Hypertension, Pregnancy-Induced | Other: Physical measurement Other: Cuff size fitting |
Study Type : | Observational |
Actual Enrollment : | 300 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Arm and Finger Measurement for Blood Pressure Surveillance |
Actual Study Start Date : | July 10, 2019 |
Actual Primary Completion Date : | December 11, 2019 |
Estimated Study Completion Date : | December 31, 2021 |
Group/Cohort | Intervention/treatment |
---|---|
Pregnant cohort
Parturients of gestational age >= 32 weeks will have measurements of arm length, MAC, proximal arm circumference, distal arm circumference, finger circumference to generate the conicity index.
|
Other: Physical measurement
Parturients of gestational week >= 32 weeks will have their arms and fingers measured to generate the conicity index.
Other Name: Measurement of fingers and arms
Other: Cuff size fitting Fit on arm cuff and finger cuff as selected by investigators based on the measurement.
Other Name: Cuff fitting for arm and finger
|
Ages Eligible for Study: | 21 Years to 50 Years (Adult) |
Sexes Eligible for Study: | Female |
Gender Based Eligibility: | Yes |
Gender Eligibility Description: | Pregnant female in third trimester (>=32 weeks gestation) |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
Singapore | |
KK Women's and Children's Hospital | |
Singapore, Singapore, 229899 |
Principal Investigator: | Farida Ithnin, MMED (Anaes) | KK Women's and Children's Hospital |
Tracking Information | |||||||
---|---|---|---|---|---|---|---|
First Submitted Date | May 27, 2019 | ||||||
First Posted Date | July 9, 2019 | ||||||
Last Update Posted Date | April 13, 2021 | ||||||
Actual Study Start Date | July 10, 2019 | ||||||
Actual Primary Completion Date | December 11, 2019 (Final data collection date for primary outcome measure) | ||||||
Current Primary Outcome Measures |
|
||||||
Original Primary Outcome Measures | Same as current | ||||||
Change History | |||||||
Current Secondary Outcome Measures |
|
||||||
Original Secondary Outcome Measures | Same as current | ||||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||||
Descriptive Information | |||||||
Brief Title | Arm and Finger Measurement for Blood Pressure Surveillance | ||||||
Official Title | Arm and Finger Measurement for Blood Pressure Surveillance | ||||||
Brief Summary | Accurate blood pressure (BP) measurement is critical in peripartum care. The cuff and bladder sizes affects the accuracy of BP measurement. Current international BP measurement recommendations are based on mid-arm circumference (MAC). However, evidence have shown the discrepancies between these sizes, leading to inaccuracy of BP measurement. This study will measure arm and finger size of 300 parturients in third trimester to determine whether the MAC, finger measurement or body mass index (BMI) is the best clinical predictor for non-standard cuff sizes for BP measurement. | ||||||
Detailed Description | Accurate blood pressure (BP) measurement plays an important role in peripartum care as it is essential in detecting hypertensive disorders in pregnancy and medical decision making during the pregnancy. The cuff and bladder size have been highlighted as an important factor affecting the accuracy of BP measurement. Current international BP measurement recommendations are based on mid-arm circumference (MAC) assuming the arm is cylindrical in shape. However, evidence have shown a mismatch between these sizes, leading to BP overestimation or underestimation in obese patients. This is because the shape of the arm is a truncated cone instead of a cylinder, and the cuff will expand irregularly during inflation thus yielding inaccurate BP measurements. This is especially evident in Asian pregnant patients whereby no available guideline can recommend a suitable cuff for parturients with different MAC. Nexfin is a finger cuff device that can be a suitable alternative BP measurement device for such patients. In this study 300 parturients will be recruited in third trimester and undergoing nonemergent caesarean section in KKH. Patients' arm and finger sizes will be measured, and their user experience on current practices on BP measurement. The arm measurements will help to identify the proportion of women that may require non-standard cuff sizes for BP measurement. A conicity index will be determined whether the MAC, finger measurement or BMI is the best clinical predictor. The finger measurements will also help to determine the proportion of women that may require non-standard cuff sizes on the Nexfin device for BP measurement. The knowledge gathered in this pilot study will be used to design future studies in which the accuracy of Nexfin will be compared with standard BP measurement, which in turn will improve BP detection, subsequent patient monitoring and satisfaction. | ||||||
Study Type | Observational | ||||||
Study Design | Observational Model: Cohort Time Perspective: Prospective |
||||||
Target Follow-Up Duration | Not Provided | ||||||
Biospecimen | Not Provided | ||||||
Sampling Method | Non-Probability Sample | ||||||
Study Population | Pregnant women in Singapore | ||||||
Condition | Hypertension, Pregnancy-Induced | ||||||
Intervention |
|
||||||
Study Groups/Cohorts | Pregnant cohort
Parturients of gestational age >= 32 weeks will have measurements of arm length, MAC, proximal arm circumference, distal arm circumference, finger circumference to generate the conicity index.
Interventions:
|
||||||
Publications * |
|
||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||
Recruitment Information | |||||||
Recruitment Status | Active, not recruiting | ||||||
Actual Enrollment |
300 | ||||||
Original Estimated Enrollment | Same as current | ||||||
Estimated Study Completion Date | December 31, 2021 | ||||||
Actual Primary Completion Date | December 11, 2019 (Final data collection date for primary outcome measure) | ||||||
Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||||
Sex/Gender |
|
||||||
Ages | 21 Years to 50 Years (Adult) | ||||||
Accepts Healthy Volunteers | No | ||||||
Contacts | Contact information is only displayed when the study is recruiting subjects | ||||||
Listed Location Countries | Singapore | ||||||
Removed Location Countries | |||||||
Administrative Information | |||||||
NCT Number | NCT04012151 | ||||||
Other Study ID Numbers | ARMFIN ANAESPRG19/012 ( Other Identifier: SingHealth ANAES ACP ) |
||||||
Has Data Monitoring Committee | No | ||||||
U.S. FDA-regulated Product |
|
||||||
IPD Sharing Statement |
|
||||||
Responsible Party | KK Women's and Children's Hospital | ||||||
Study Sponsor | KK Women's and Children's Hospital | ||||||
Collaborators | Not Provided | ||||||
Investigators |
|
||||||
PRS Account | KK Women's and Children's Hospital | ||||||
Verification Date | February 2021 |